Antisense oligonucleotides that decrease Bcl-2 expression caused direct tumour suppression and increased sensitivity to cytotoxic chemotherapy in preclinical models (Cotter et al, 1994; Jansen et al, 1998). This evidence concerns the gene BCL2 and neoplasm.